SPP1 and neoplasm: Strong osteopontin expression in tumor cells has been shown in a variety of cancer types and is associated with poor prognosis and metastasis including gastric, ovarian, lung, breast, prostate, liver, sarcomas, colon, renal, and head and neck cancers [15-18].